GlaxoSmithKline Consumer Healthcare Limited announces results for the quarter 1, 2017

GlaxoSmithKline Consumer Healthcare Limited announces results for the quarter ended June 30, 2017

 

Highlights for the first quarter ended June 30, 2017

  • Our health food drink portfolio continues to be the market leader with 55.9% (Value share) and 64.1% (Volume share) – (MAT Jun, 2017)
  • Sales for the quarter is at 991 Cr and Profit before tax (PBT) at 204 Cr

 

Gurugram, 08 August, 2017: GlaxoSmithKline Consumer Healthcare Limitedtoday declared its financial results for the first quarter ended June 30, 2017. The quarter recorded sales at Rs. 991 crores decrease of 1% and PBT at Rs. 204 crores decrease by 17% compared to same period last year mainly on account of CSD consumption loss and destocking of wholesale channels as trades sentiments remained cautious due to GST implementation. This led to softer consumption and reduced trade pipelines, yet, the company managed to remain the market leader in the health food drinks category.

Commenting on the results, Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “The overall business environment remained tepid during the quarter largely on the account of destocking of goods in wholesale channels and CSD consumption loss ahead of GST implementation. We continue to drive brand building initiatives through stepped up investments in our brands, innovations and consumer-connect activities. With good predicted monsoons, we are optimistic about the coming quarters.”

He further said “Science, innovation and consumer insights will continue to differentiate us from others. Horlicks Growth+ has received good response from consumers and clocked second highest volume delivery indicating sustained consumer confidence in our products. Our sachet portfolio has ensured last mile access to our products and delivered a healthy volume growth.”

Performance Highlights:

  • Horlicks Growth+ clocked second highest volume delivery indicating sustained consumer confidence
  • Mother’s Horlicks became the No.1 expert recommended pregnancy nutrition HFD*
  • Boost continued to maintain growth momentum

Health Food Drinks – Market share

  • Our health food drink portfolio continues to be the market leader with 55.9% (Value share) and 64.1% (Volume share) – (MAT Jun, 2017)
  • Horlicks at 44.2%(Value share) and 49.9%(Volume share) (MAT Jun, 2017)
  • Boost at 11.3%(Value share) and 13.8% (Volume share) (MAT Jun, 2017)

 

*According to CMARC prescription audsit

 

About GlaxoSmithKline Consumer Healthcare Ltd

GSK Consumer Healthcare Ltd is the category leader in Indian health food drinks industry. Our flagship product Horlicks leads the market, while Boost is among the top three health food drink brands that India prefers. Our manufacturing plants are located in Nabha, Rajahmundry and Sonepat. In India we have an engaged workforce of over 4300 employees. GSK also markets and distributes a range of everyday health products such as Eno, Crocin, Iodex and Sensodyne. Our marketing and distribution network comprises over 850 distributors and a direct coverage of over 3.3 million retail outlets.

 

GSK Consumer Healthcare Ltd is an associate of GlaxoSmithKline plc. of U.K, one of world’s largest consumer healthcare companies. We have a heritage that goes back over 160 years. Our purpose is to help more people around the world to do more, feel better and live longer with everyday healthcare products.  Our goal is to build a global, growing business - we call a Fast Moving Consumer Healthcare (FMCH) company - dedicated to everyday healthcare with all of the scientific expertise and quality guarantees that demands, working at the speed and with the genuine consumer understanding the modern world expects.

 

GSK Consumer Healthcare globally owns some of the world’s best loved healthcare brands, successful in over 100 countries. These include Sensodyne, Voltaren, Theraflu, Paradontax, Panadol, Polident, Otrivin, Horlicks and Physiogel.

 

Media Contacts

Genesis Burson-Marsteller

Sakshi Mathur: sakshi.mathur@bm.com / +91 9999007585

M Sindhu: m.sindhu@bm.com /+91 9899428304

 

GlaxoSmithKline Consumer Healthcare

Deepa Dey: deepa.d.dey@gsk.com

Kinshuk Gupta: kinshuk.x.gupta@gsk.com